Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, January 2006

Sort by: Newest first Oldest first A-Z Z-A

  • Could nutraceuticals be a further weapon in the battle for weight loss?

    7 JAN 2006 0:00

    The authors are from the School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester M13 9PL. Correspondence to: Dr Lockwood e-mail

  • Resolutions revisited Subscription

    7 JAN 2006 0:00

    This week, many people will be counting the cost to their bodies of over-indulgence during the Christmas and New Year celebrations. There is no better antidote than to cut down on calorie intake and alcohol consumption, drink more water and have a few early nights.

  • Might oseltamivir be a mixed blessing? Subscription

    7 JAN 2006 0:00

    The antiviral oseltamivir (Tamiflu) is a mainstream of UK government policy for dealing with pandemic influenza.1 As flu pandemic co-ordinators struggle to make viable local plans for its storage and distribution, the mixed blessing it creates becomes more apparent.

  • Paying bonuses is not a sensible way to improve preregistration training Subscription

    7 JAN 2006 0:00

    Riaz Firfirey argues that the lump sum paid to community pharmacies for training preregistration pharmacists should be reduced, with a bonus at the end of the year for giving the student a satisfactory report (PJ, 17 December 2005, p752).

  • What is the POEM evidence for celecoxib? Subscription

    7 JAN 2006 0:00

    I wish to respond to the letter from Chris Walker, of Pfizer Ltd (PJ, 24/31December 2005, p773). His letter is similar to one published in the BMJ of 17 December (p1473) from Joe Feczko, chief medical officer at Pfizer, New York. Both these letters claim that celecoxib has a

  • A pragmatic answer to consumer protection can be found Subscription

    7 JAN 2006 0:00

    Recent years have seen an upsurge in demand for complementary and alternative medicines. Concomitantly, CAM research in academic institutions has increased. Yet results have been disappointing, inconclusive and have done CAM no favours.

  • Clarification Subscription

    7 JAN 2006 0:00

    I think Priya Sejpal (PJ, 10 December 2005, p719) has missed the point I was trying to make (PJ, 3 December 2005, p685). I was not referring specifically to amending computer-generated prescriptions but to any

  • MURs take more than a few minutes Subscription

    7 JAN 2006 0:00

    I have been conducting medicines use reviews (MURs) in an independent pharmacy for the past three months. I am a self-employed locum so patients do not know me before the appointment. The pharmacist manager gives written and verbal information to the patients, who have been referred by the GP or, more commonly, selected following primary care trust guidelines.

  • Common sense! Subscription

    7 JAN 2006 0:00

    I have just realised how lucky we pharmacists are. For years I have worried about what to do (i) if a person with disabilities is unable to remove tablets from a blister pack, (ii) if the same person cannot pour from a bottle into a 5ml spoon, (iii) if he or she cannot read normal labels and (iv) if he or she cannot understand why they need to take

  • Out on the spice trail / Road ahead in 2006 / Use of animals in drug testing is urgently due for re-evaluation Subscription

    7 JAN 2006 0:00

    Out on the spice trail January 6 is the Christian celebration of the feast of Epiphany (“manifestation”), also observed as the 12th day of Christmas, when Christmas trees are removed from the house and decorations are taken down.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.